Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel ...
Q2 2026
Jul 30, 2026
Q1 2026
May 8, 2026
FY 2025
Mar 4, 2026
Q4 2025
Q3 2025
Nov 5, 2025